PRINCETON, N.J.–(BUSINESS WIRE)—- $BMY #ASH–Bristol Myers Squibb Demonstrates Breadth and Clinical Momentum Across Blood Cancers and Rare Hematologic Disorders at ASH 2026
PRINCETON, N.J.–(BUSINESS WIRE)—- $BMY #ASH–Bristol Myers Squibb Demonstrates Breadth and Clinical Momentum Across Blood Cancers and Rare Hematologic Disorders at ASH 2026